BioViotica

Butylcycloheptylprodigiosin

CHF 100.00
In stock
BVT-0423-C250250 µgCHF 100.00
BVT-0423-M0011 mgCHF 305.00
More Information
Product Details
Synonyms Butyl-ortho-cycloheptylprodiginine, BCHP
Product Type Chemical
Properties
Formula

C25H33N3O

MW 391.6
CAS 352304-41-7
Source/Host Chemicals Isolated from Streptomyces parvulus.
Purity Chemicals ≥93% (NMR)
Appearance Red solid.
Solubility Soluble in DMSO, methanol, acetone or chloroform.
Identity Determined by 1H-NMR.
Declaration Manufactured by BioViotica.
InChi Key ZBKQNSZMEUHFKN-JTOYMXJDSA-N
Smiles CCCC[C@H]1CCCCCCC2=C1C=C(C2)\C=C1/N=C(C=C1OC)C1=CC=CN1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Store solutions at -20°C in the dark.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description
  • Tripyrrolic pigment like prodigiosin.
  • Antimalarial agent.
  • Anticancer agent with multiple modes of action.
  • Immunosuppressant in non-toxic concentrations.
  • Bone resorption inhibitor.
  • Antiulcer agent.
Product References
  1. A new prodiginine (prodigiosin-like) pigment from Streptomyces. Antimalarial activity of several prodiginines: N. N. Gerber; J. Antibiot. 28, 194 (1975)
  2. Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years: A. Furstner; Angew. Chem. Int. Ed. 42, 3582 (2003)
  3. Chasing a Phantom by Total Synthesis: The Butylcycloheptylprodigiosin Case: A. Fürstner, et al.; Angew. Chem. Int. Ed. Engl. 44, 2777 (2005)
  4. The biosynthesis and regulation of bacterial prodiginines: N. R. Williamson, et al.; Nat. Rev. Microbiol. 4, 887 (2006) (Review)
  5. Total synthesis, molecular editing and evaluation of a tripyrrolic natural product: the case of 'butylcycloheptylprodigiosin': A. Furstner, et al.; Chem. Eur. J. 13, 1929 (2007)
  6. A concise synthesis of butylcycloheptylprodigiosin: J. T. Reeves; Org. Lett. 9, 1879 (2007)
  7. Butylcycloheptylprodigiosin and undecylprodigiosin are potential photosensitizer candidates for photodynamic cancer therapy: Z. Arshadi, et al.; Mol. Biol. Rep. 48, 5965 (2021)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.